Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin
Clinical trial NCT00006043 · COMPLETED
Trial details
- NCT number
- NCT00006043
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-02-01
- Primary completion
- 2001-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.